These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 9845355

  • 1. Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells.
    Yang CP, Galbiati F, Volonte D, Horwitz SB, Lisanti MP.
    FEBS Lett; 1998 Nov 20; 439(3):368-72. PubMed ID: 9845355
    [Abstract] [Full Text] [Related]

  • 2. Role of caveolin-1 in etoposide resistance development in A549 lung cancer cells.
    Bélanger MM, Gaudreau M, Roussel E, Couet J.
    Cancer Biol Ther; 2004 Oct 20; 3(10):954-9. PubMed ID: 15326378
    [Abstract] [Full Text] [Related]

  • 3. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line.
    Wang NN, Zhao LJ, Wu LN, He MF, Qu JW, Zhao YB, Zhao WZ, Li JS, Wang JH.
    Asian Pac J Cancer Prev; 2013 Oct 20; 14(9):4983-8. PubMed ID: 24175763
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells.
    Lavie Y, Fiucci G, Liscovitch M.
    J Biol Chem; 1998 Dec 04; 273(49):32380-3. PubMed ID: 9829965
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Up-regulation of caveolin expression by cytotoxic agents in drug-sensitive cancer cells.
    Bélanger MM, Roussel E, Couet J.
    Anticancer Drugs; 2003 Apr 04; 14(4):281-7. PubMed ID: 12679732
    [Abstract] [Full Text] [Related]

  • 14. Multidrug resistance phenotype and paclitaxel (Taxol) sensitivity in human renal carcinoma cell lines of different histologic types.
    Reinecke P, Schmitz M, Schneider EM, Gabbert HE, Gerharz CD.
    Cancer Invest; 2000 Apr 04; 18(7):614-25. PubMed ID: 11036469
    [Abstract] [Full Text] [Related]

  • 15. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
    Lee FY, Borzilleri R, Fairchild CR, Kim SH, Long BH, Reventos-Suarez C, Vite GD, Rose WC, Kramer RA.
    Clin Cancer Res; 2001 May 04; 7(5):1429-37. PubMed ID: 11350914
    [Abstract] [Full Text] [Related]

  • 16. Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol(R)).
    Kowalski RJ, Giannakakou P, Hamel E.
    J Biol Chem; 1997 Jan 24; 272(4):2534-41. PubMed ID: 8999970
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pregnane X receptors regulate CYP2C8 and P-glycoprotein to impact on the resistance of NSCLC cells to Taxol.
    Chen Y, Huang W, Chen F, Hu G, Li F, Li J, Xuan A.
    Cancer Med; 2016 Dec 24; 5(12):3564-3571. PubMed ID: 27878971
    [Abstract] [Full Text] [Related]

  • 19. Triptolide reverses the Taxol resistance of lung adenocarcinoma by inhibiting the NF-κB signaling pathway and the expression of NF-κB-regulated drug-resistant genes.
    Jiang N, Dong XP, Zhang SL, You QY, Jiang XT, Zhao XG.
    Mol Med Rep; 2016 Jan 24; 13(1):153-9. PubMed ID: 26531258
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.